Control of hypertension among diabetic patients in a referral hospital in Tanzania: a cross-sectional study by Kilonzo, Semvua B. et al.
              
                Control of Hypersention among Diabetic Patients…                               Semvua B.K. et al.                                       
 
 





Control of Hypertension among Diabetic Patients in a Referral 




, Daniel W. Gunda
1,2





, Henry A. Mayala
4









OPEN ACCESS  
 
Citation: Semvua B. Kilonzo, Daniel W. 
Gunda, Fatma A. Bakshi, Fredrick 
Kalokola, Henry A. Mayala,   Hollo 
Dadi.Control of Hypertension among 
Diabetic Patients in a Referral Hospital in 
Tanzania: A Cross-Sectional Study. J 
Health Sci 2017;27(5):473. 
doi:http://dx.doi.org/10.4314/ejhs.v27i5.5  
Received: February 14, 2017  
Accepted: April 23, 2017 
Published: September 1, 2017  
Copyright: © 2017 Semvua B. K, et al. 
This is an open access article distributed 
under the terms of the Creative Commons 
Attribution License, which permits 
unrestricted use, distribution, and 
reproduction in any medium, provided the 
original author and source are credited. 
Funding:  Nil 
Competing Interests: The authors 
declare that this manuscript was approved 
by all authors in its form and that no 
competing interest exists. 
Affiliation and Correspondence: 
1Department of Internal Medicine, 
Catholic University of Health and 
Allied Sciences, Mwanza-Tanzania 
2Department of Internal Medicine, 
Bugando Medical Centre,Mwanza-
Tanzania 
3Faculty of Undergraduate Studies, 
Weill School of Medicine, Mwanza-
Tanzania 4Cardiovascular department, 
Jakaya Kikwete Cardiac Institute,  
Dar es Salaam-Tanzania 








 BACKGROUND: Hypertension is common among diabetic 
patients. The co-existence of two conditions carries an excessive 
risk of severe complications and mortalities. Limited information 
exists on the determinants of poor hypertension control among 
these patients. We aimed at determining the prevalence and factors 
associated with poor hypertension control in these patients. 
METHODS: Data of diabetic patients who were also hypertensive 
attending an outpatient clinic from 1 August 2015 to 31 December 
2015 at Bugando Medical Centre were retrospectively analyzed. 
Uncontrolled hypertension was defined as a blood pressure of 
≥130mmHg and/or ≥80mmHg systolic and diastolic respectively. A 
designed questionnaire was used to collect data of patients. 
Continuous variables were summarized by median and 
interquartile ranges (IQR) and categorical variables were 
summarized by frequency and percentage. Logistic regression was 
used to find the predictors of uncontrolled hypertension. 
RESULTS: The majority of our study population were females, 
161/295 (54.6%), and the median age was 57 years (IQR 50-64). 
The prevalence of hypertension was 206/295 (69.8%). A total of 
174/206 (84.5%) patients had uncontrolled hypertension. This poor 
control was significantly associated with poor adherence to anti-
hypertensives (OR 1.73[1.26-2.38] p=0.002), presence of any long-
term complication (OR 3.19 [1.65-6.18] p=0.03) and overweight 
(BMI>24.9 Vs <24.9) (OR 1.68 [0.98-2.88], p=0.04). Under-
prescription and ambiguous drugs combination was also observed. 
CONCLUSION: The prevalence of poor hypertension control 
among diabetic patients in Tanzania is alarming. Most of the 
factors associated with this situation can be modified. The 
clinicians should advocate individualized management, continuous 
health education and adherence to the available guidelines. 








               
  Ethiop J Health Sci.                           Vol. 27, No. 5                     September 2017 
 
 






There is a growing evidence that the burden of 
non-communicable diseases (NCDs) is rapidly 
increasing in sub-Saharan Africa (SSA) (1–3). 
Estimates of age-standardized mortality suggest 
that patients in SSA may have up to three-fold 
higher mortality rates than similar European 
cohorts for non-communicable diseases. Diabetes 
mellitus (DM) and hypertension are common 
diseases in Africa with high mortalities (4). 
Hypertension, a common comorbid in diabetes, 
affects more than 50% of diabetic patients (5–7). 
It is clear that the co-existence of these two 
conditions in  a patient carries an excessive risk 
for both micro- and macro-vascular complications, 
and mortalities (8). A Framingham study, one of 
the largest meta-analysis surveys, showed a strong 
association between the two diseases. Co-
existence of hypertension in diabetics is attributed 
to the risk of death and cardiovascular events by 
44% and 41% respectively as compared to 7% and 
9% risk by diabetes alone (9).  
Blood pressure lowering in diabetic patients 
has a remarkable cardiovascular (CV) protective 
effect. Guidelines from the Joint National 
Committee (JNC-7) and American Diabetes 
Association (ADA) recommend maintaining blood 
pressure at <130mmHg systolic and <80mmHg 
diastolic in patients with diabetes. Usually, 
multiple anti-hypertensive agents are needed to 
achieve this goal  (8,10). In most cases, adequate 
control of blood pressure (BP) in these patients is 
not attained (5,7,11). Information on the 
prevalence, control and risk factors of poor control 
of hypertension among diabetic patients in 
Tanzania is scarce. The objectives of this study 
were to determine the prevalence of hypertension 
among diabetics, to evaluate the degree of BP 
control, to describe the factors associated with 
poor BP control, and to evaluate the patterns of 
antihypertensive treatment prescription. 
 
MATERIALS AND METHODS 
 
This cross-sectional study was conducted in a 
diabetic clinic at Bugando Medical Centre (BMC). 
BMC is the zonal hospital for the Lake Victoria 
region in Northwest Tanzania, and it serves a 
population of approximately 13 million people. 
The clinic follows around 1000 diabetic patients 
from Mwanza region and referrals from around 
the Lake Zone. This study was conducted over a 
period of four months starting from August 2015. 
 
Study population: We retrospectively reviewed 
clinical records of all patients who were attending 
our diabetic clinic from 01 August to 31 
December 2015. Patients were excluded if they 
were younger than 18 years or pregnant. Patients’ 
age, gender, occupation, smoking history, duration 
of diabetes, history of hypertension, use of 
antihypertensive and/or hypoglycemic drugs were 
recorded on structured questionnaires. Smoking 
history in this study was defined as being either 
previous or current smoker. Poor adherence to 
medications was defined as a patient’s self-
reported use of <80% of the prescribed drugs. This 
cut-off is widely acceptable and has been used in 
other studies for chronic drugs adherence (12). 
Other related clinical information was also 
documented. This included height, weight, blood 
pressures, Fasting Blood Glucose (FBG), 
cholesterol levels, presence of any documented 
chronic complication(s) and use of other long term 
medications. Body Mass Index (BMI) was 
calculated as kg/m
2 
using the most recent records. 
The mean blood pressure from three recent visits 
was used to assess the degree of blood pressure 
control. Controlled hypertension was defined as 
the mean BP of <130/80mmHg. FBG 
measurements were also recorded. The mean FBG 
from three recent visits was used to define the 
Glycemic control. Patients were labeled to have 
poor glycemic control when average FBG was 
>7.0mmol/L. Glycosylated hemoglobin (HbA1C) 
was not done in these patients. The mean FBG  of 
7.0Mmol/L, which has been used as a cut-off point 
in this study, is justified by its correlation to 
around 6% HbA1C (13). The mean total 
cholesterol level from two recent consecutive 
visits was used to define the total cholesterol in 
this study. 
Ethical statement: The study was approved by  
Bugando Medical Centre/ Catholic University of 
Health and Allied Sciences (BMC/CUHAS)  joint 
Committee of Research and Publications.  
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Data analysis: Data was entered, verified and 
cleaned using Microsoft excel and analysis was 
done using STATA version 14 (College Station, 
Texas). Continuous variables were summarized by 
medians and interquartile ranges (IQRs), and 
categorical variables were summarized by 
frequency and percentage. Logistic regression was 
used to find the predictors of poor blood pressure 
control. Comparisons between the two groups 
were computed using chi-squared test for 
categorical variables, nonparametric Wilcoxon 
rank-sum test for continuous variables and student 




Baseline characteristics of 295 enrolled patients 
attending diabetic clinic at BMC: A total of 295 
patients attending diabetic clinic at the BMC from 
August to December 2015 fulfilled the inclusion 
criteria. Among these patients, 161/295 (54.6%) 
were females. The median age was 57 years (IQR 
50-64). The mean Body Mass Index (BMI) of our 
patients was high 27 kg/m
2 
(IQR 24-30). The 
mean duration of diabetes was 48-months (IQR 
22-120), and hypoglycemic (anti-diabetic) drugs 
were  prescribed to all patients. An average FBG 
in three consecutive visits was 9.6 (6.9-13.6) 
Mmol/dL (Table 1). 
 
Table 1: Baseline characteristics of 295 enrolled diabetic patients attending diabetic clinic at BMC 
 
Characteristic  Number (%)  or median (IQR) 
Sex Male 134 (45.4) 
 Female 161 (54.6) 
Age in years  57 (50-64) 
BMI (kg/m
2
)  27 (24-30) 
Marital status Single 5 (1.78) 
 Married 79 (27.9) 
 Divorced 145 (51.2) 
 Widowed 54 (19.0) 
Address Mwanza city 103 (34.9) 
 Outside of Mwanza city 192 (65.1) 
Work status Informal employment 196(66.7) 
 Formal employment  76 (25.9) 
 Retired 22 (7.5) 
Smoking history Yes 32 (10.9) 
 No 262 (89.1) 
Duration of DM (months)  48 (22-120) 
Duration on Anti-diabetics (Months)  36 (14-84) 
Average FBG (Mmol/dl) (3 consequent visits)  9.6 (6.9-13.6) 
Hypertensive Yes 206 (69.8) 
 No 89 (43.2) 
Possession of any health insurance Yes 91 (31.2) 
 No 201 (68.8) 
 
Prevalence of blood pressure control among 
diabetic patients attending diabetic clinic at 
BMC: Out of 295 diabetic patients attending 
diabetic clinic, 206(69.8%) were hypertensive. 
The median systolic and diastolic blood pressures 
were 140 (120-150) mmHg and 84 (78-89) mmHg 
respectively. A total of 174/206 (84.5%) patients 
had uncontrolled BP (≥130/80mmHg).  
 
Characteristics of 206 diabetic patients with 
hypertension attending diabetic clinic at BMC: 
Table 2 displays the baseline and clinical 
characteristics of hypertensive-diabetic patients.  
Fifty-six percent of these patients were females. 
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Many hypertensive patients, 117 (56.8%), were in 
the age group of 51-65 years. Severe hypertension 
was seen in 57/206(27.7%) and 40/206(19.4%) 
patients for systolic BP ≥ 160mmHg and diastolic 
≥ 100mmHg respectively. Nearly 40% of 206 had 
at least one chronic complication related to either 
Diabetes and/or hypertension. The most common 
complications reported were peripheral 
neuropathy, 23(11.2%), stroke, 21(10.2%), and 
chronic kidney disease, 16(7.8%).  
 




                          Characteristic  Number % or Median (IQR) 
Sex Female 116 (56.3) 
 Male 90 (43.7) 
Age (years)  58 (IQR 53-65) 
Age group (years) <35 8 (3.9) 
 35-50 33 (16.0) 
 51-65 17 (56.8) 
 >65 48 (23.3) 
Smoking history  23 (11.2) 
Systolic blood pressure(mmHg) <120 39 (18.9) 
 120-139 56 (27.2) 
 140-159 54 (26.2) 
 ≥160 57 (27.7) 
Diastolic blood pressure (mmHg) <80 43 (20.8) 
 80-89 78 (37.9) 
 90-99 45 (21.8) 
 ≥100 40 (19.4) 
Duration of using anti-hypertensives (Months)  48 (24-108) 
Duration of DM (Months)  65 (26-120) 
Average Fasting Blood Glucose (Mmol/dL) FBG <7 57 (27.7) 
 FBG ≥7≤11 69 (33.5) 
 FBG >11 80 (38.3) 
Average total Cholesterol (Mmol/L)  4.8 (3.8-6.1) 
Patients with documented complications  81 (39.3) 
Types of complications documented Peripheral neuropathy 23 (11.2) 
 Stroke 21 (10.2) 
 Chronic Kidney Disease 16 (7.8) 
 Retinopathy 13 (6.3) 
 Ischemic Heart Disease 4 (1.9) 
 Peripheral Vascular Disease 2 (1.0) 
 Diabetic Foot Ulcer 1 (0.5) 
Using other long term drugs  114 (59.1) 
Types of drugs used Statins 66 (57.9) 
 Aspirin 35 (30.7) 
 Tricyclic anti-depressants 12 (10.52) 
 
Predictors of hypertension control among 
diabetic patients with hypertension attending 
diabetic clinic at BMC: In this study, we found 
that poor control of hypertension in diabetic 
patients was significantly associated with poor 
adherence to anti-hypertensives (OR 1.73[1.26-
2.38] p=0.002), the presence of any long-term 
complication (OR 3.19 [1.65-6.18] p=0.03) and 
overweight (BMI>24.9 Vs <24.9) (OR 1.68 [0.98-
2.88], p=0.04). Furthermore, we have also 
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demonstrated that poor BP control had a positive 
trend in the patients with the age group of 56-
65years, and those who were residing within the 
city with the odds ratio of 2.7 [95% CI, 1.1-06.9] 
(p= 0.04) and 3.1[1.1-8.3), p=0.04) respectively in 
univariate analysis. These features were not 
significant in multivariate analysis (Table 4). 
Prescription pattern of anti-hypertensives 
among diabetic patients: All, except one patient, 
were prescribed on at least one antihypertensive 
drug and among them 105 (51.2%), 80 (39.0%) 
and 9(4.4%) were on monotherapy, two drugs 
combination and three/more drugs combination 
respectively. Median duration on anti-
hypertensives was 48 months (IQR 24-108). 
Types of anti-hypertensives used were 
Angiotensin II converting enzyme Inhibitors 
(ACEI) 112 (54.6%) and angiotensin II receptor 
blocker (ARB) 62 (30.2%), Calcium channel 
blockers (CCB) 92 (44.9%), Beta-Blockers (BB) 8 
(3.9%), Diuretics 7 (3.4%) and Hydralazine 6 
(2.9%). Details of anti-hypertensives prescription 
pattern have been shown in Table 3. 
 
 





In this study, we found that nearly 70% of diabetic 
patients had hypertension and only few (15.5%) 
reached their target BP values. Poor adherence to 
anti-hypertensive medications, the presence of any 
long-term complication and overweight/obesity 
significantly predicted poor control of 
hypertension in these patients.  
Trends of data collected by the World Health 
Organization (WHO) suggest that the number of 
people with uncontrolled hypertension has risen 
over the recent years, and the highest being in 
Africa (30%). The prevalence of diabetes has also 
been increasing globally, particularly in middle 
and lower income countries (14). These trends 
undoubtedly reflect the reported high magnitude 
of co-morbidity between the two diseases (11–13). 
In Tanzania, Mwita et al reported the prevalence 
of hypertension among diabetic patients to be 55% 
at Muhimbili National Hospital in 2012(7), where 
lower prevalence of 29.3% was reported at the 
same center two decades ago (18). In the index 
study, we have demonstrated this magnitude to be 
much higher (69.8%). This drift clearly suggests a 
radical increase of this burden in the country.  
We have observed a low rate (15.5%) of 
control of hypertension in the index study. 
Comparably similar rates have been observed in 
Tanzania (34%), Cameroun (10.2%) and Malaysia 
(23.5%) (7,15,19). Several randomized trials have 
associated significant clinical benefits of tight BP 
control among diabetic patients (20–22). In the 
United Kingdom Prospective Diabetes Study 
(UKPDS), for instance, it was found that each 
10mmHg reduction in systolic BP was associated 
with average reduction of 15% in diabetes-related 
mortalities due to myocardial infarction (11%) and 
micro vascular complications (retinopathy and 
nephropathy) (13%) (20). Nearly 40% of our 
patients already had at least one chronic 
complication due to Diabetes/ hypertension/both. 











ACEI & CCB 
ARB & CCB 
35 (43.8) 
22 (27.5) 
BB, CCB & Hydralazine 









ACEI & ARB 
BB & CCB  
8 (10.0) 
5 (6.3) 
ACEI, CCB & Hydralazine 









CCB & Diuretics 
ARB & Diuretics 
3 (3.8) 
1 (1.3) 
ACEI, ARB & BB 1(11.1) 
   ACEI & Diuretics 1 (1.3)   
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Table 4: Logistic regression analysis for predictors of poor control of blood pressure among diabetic 
patients with hypertension attending diabetic clinic at BMC 
 





BP (%) n=174 
  Unadjusted 
OR (95% CI)      P 
value 
   Adjusted 
OR (95%CI)        P 
value 
Sex Female 14 (43.8) 102 (58.6) 0.55(0.26-1.17) 0.12   
 Male 18 (56.3) 72 (41.4)     
Age (years) >65 6 (18.8) 42 (24.1) 1.4 (0.5-3.7) 0.51   
 56-65 6(18.8) 67(38.5) 2.7(1.1-6.9) 0.04   
 46-55 14 (43.8) 46 (26.4) 0.5(0.2-1.0) 0.05   
 36-45 3(9.4) 11(6.3) 0.7(0.2-2.5) 0.53   
 <36 3(9.4) 8(4.6) 0.5(0.1-1.9) 0.28   
BMI >24.9 28 (87.5) 162(93.1) 2.9(1.0-8.0) 0.02 1.7(1.0- 2.9) 0.04 
 <24.9 4 (12.5) 12 (6.9)     
Occupation Unemployed 18 (56.3) 115 (66.5) 1.0 (0.6-1.5) 0.86   
 Employed 12 (37.5) 41 (23.7)     
 Retired 2(6.3) 17 (9.8)     
Address Mwanza city 5(15.6) 63 (36.2) 3.1(1.1-8.3) 0.04   
 Outside Mwanza city 27 (84.4) 111(63.8)     




 12 (37.5) 52 (30.1) 1.1(.0.6-2.2) 0.57   
Duration of DM 
(months) 












































 BB 1(3.2) 7 (4.0) 1.3 (0.2-10.6) 0.83   
 Diuretics 0 7 (4.0) * *   
 Hydralazine 0 6 (3.5) * *   
Good adherence  31 (96.6) 138 (79.3) 2.13(1.47-3.09) <0.0
01 
2.12(1.10- 4.08) 0.002 
Documented 
complications 
 7 (21.9) 74 (42.5) 2.64(1.08-6.44) 0.03 3.19(1.65- 6.18) 0.01 
 
Good adherence to anti-hypertensive medications 
among diabetic patients has been associated with 
better hypertension control (23) and decreased risk 
of CV disease, CV events and mortality (24). 
Similar to our findings, adherence to anti-
hypertensives among diabetic patients is generally 
poor (25,26). This might be partly caused by 
failure of the patients to prevail with increased pile 
of drugs to be taken, or potentiated side effects 
from both anti-hypertensives and hypoglycemics. 
In the case study, we have observed a direct 
association between overweight/obesity and poor 
control of BP. Similarly, a large Swedish survey 
of National Diabetes register which recruited more 
than1500 patients demonstrated the same findings. 
In this survey, both lower BMI at baseline and 
during follow-up had a favorable association for 
control of BP (27). Chew et al reported  similar 
findings in Malaysia (19). A combination of 
Diabetes, hypertension and obesity has been 
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related with autonomic imbalance and circadian 
disruption of the autonomic tones during day and 
night periods. These effects may contribute to the 
observed findings (28).  
Most patients with diabetes require multiple 
anti-hypertensive medications to achieve the target 
blood pressure. (20,29). A meticulous combination 
of anti-hypertensive is therefore desirable. Under-
prescription of anti-hypertensives was observed in 
this study where less than one-half (43.4%) of our 
patients were prescribed on two or more anti-
hypertensives. Despite that short-coming, the 
majority of our patients were prescribed on Renin-
Angiotensin system blockers either in combination 
with other agents or as a monotherapy. This 
prescription pattern is in agreement with several 
international guidelines due to their role in 
significant reduction of CVD-related deaths, 
stroke and delaying deterioration of Glomerular 
Filtration Rate (GFR) in patients with Chronic 
Kidney Disease (CKD) (8,10,30,31). 
Unexpectedly, ACEI with ARB was prescribed in 
nine patients. This regime is not recommended as 
it does not have any added advantage (32). Human 
errors might be the reasons for these incorrect 
prescriptions. 
In conclusion, the prevalence of poor control 
of hypertension among diabetic patients in a 
tertiary hospital is high and it is highly predicted 
by modifiable factors. Incongruous prescription of 
anti-hypertensives is also evident. We believe that 
our findings will encourage health care providers 
to deliver the health services according to 
guidelines and the patient’s individualization. 
Importantly, clinicians should endlessly continue 
to provide health education on adherence, 
preventive measures and control of NCDs. Further 
follow-up studies are necessary to ascertain the 
long-term outcome of these patients.  
This study has limitations. Being a cross 
sectional study, the fate of diabetes and 
hypertension co-morbidity could not be assessed. 
The time from diagnosis of diabetes and 
hypertension could also not be evaluated. Despite 
these shortcomings, we believe that these findings 
are important and relevant as they provide a broad 
picture of the situation locally and a baseline 
information for further studies on the subject. 
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